Abstract:Description Since the early 2000s, there has been a rapid decline in colorectal cancer (CRC) mortality, due in large part to screening and removal of precancerous polyps. Despite these improvements, CRC remains the second leading cause of cancer deaths in the United States, with approximately 53,000 deaths projected in 2023. The aim of this American Gastroenterological Association (AGA) Clinical Practice Update Expert Review was to describe how individuals should be risk-stratified for CRC screening and post-polypectomy surveillance and to highlight opportunities for future research to fill gaps in the existing literature. Methods This Expert Review was commissioned and approved by the American Gastroenterological Association (AGA) Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology . These Best Practice Advice statements were drawn from a review of the published literature and from expert opinion. Because systematic reviews were not performed, these Best Practice Advice statements do not carry formal ratings regarding the quality of evidence or strength of the presented considerations. Best Practice Advice Statements Best Practice Advice 1 All individuals with a first-degree relative (defined as a parent, sibling, or child) who was diagnosed with CRC, particularly before the age of 50 years, should be considered at increased risk for CRC. Best Practice Advice 2 All individuals without a personal history of CRC, inflammatory bowel disease, hereditary CRC syndromes, other CRC predisposing conditions, or a family history of CRC should be considered at average risk for CRC. Best Practice Advice 3 Individuals at average risk for CRC should initiate screening at age 45 years and individuals at increased risk for CRC due to having a first-degree relative with CRC should initiate screening 10 years before the age at diagnosis of the youngest affected relative or age 40 years, whichever is earlier. Best Practice Advice 4 Risk stratification for initiation of CRC screening should be based on an individual's age, a known or suspected predisposing hereditary CRC syndrome, and/or a family history of CRC. Best Practice Advice 5 The decision to continue CRC screening in individuals older than 75 years should be individualized, based on an assessment of risks, benefits, screening history, and comorbidities. Best Practice Advice 6 Screening options for individuals at average risk for CRC should include colonoscopy, fecal immunochemical test, flexible sigmoidoscopy plus fecal immunochemical test, multitarget stool DNA fecal immunochemical test, and computed tomography colonography, based on availability and individual preference. Best Practice Advice 7 Colonoscopy should be the screening strategy used for individuals at increased CRC risk. Best Practice Advice 8 The decision to continue post-polypectomy surveillance for individuals older than 75 years should be individualized, based on an assessment of risks, benefits, and comorbidities. Best Practice Advice 9 Risk-stratification tools for CRC screening and post-polypectomy surveillance that emerge from research should be examined for real-world effectiveness and cost-effectiveness in diverse populations (eg, by race, ethnicity, sex, and other sociodemographic factors associated with disparities in CRC outcomes) before widespread implementation.

Evaluation of a risk index for advanced proximal neoplasia of the colon

Advanced proximal neoplasia of the colon in average-risk adults

Development and Validation of the Asia-Pacific Proximal Colon Neoplasia Risk Score

Identification of Subjects at Risk of Proximal Advanced Neoplasia for Colorectal Cancer Screening

Development of a risk scoring system for predicting advanced colorectal neoplasia within subcentimetric polyps: A population-based study

A Validated Scoring System to Predict Proximal Neoplasia for Colorectal Cancer Screening

Validation Of A Risk Prediction Score For Proximal Neoplasia In Colorectal Cancer Screening: A Prospective Colonoscopy Study

Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults

Evaluating the use of environmental and polygenic risk scores to inform colorectal cancer risk-based surveillance intervals

The Discriminatory Capability Of Existing Scores To Predict Advanced Colorectal Neoplasia: A Prospective Colonoscopy Study Of 5,899 Screening Participants

IDDF2022-ABS-0156 Risk Score for Advanced Colorectal Neoplasia in Symptomatic Individuals: a Derivation and Validation Study

A prognostic model for advanced colorectal neoplasia recurrence

Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals

Polygenic Risk Score for Defining Personalized Surveillance Intervals after Adenoma Detection and Removal at Colonoscopy.

Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)

New Prognostic Risk Score for Predicting In-Hospital Mortality in Geriatric Patients Undergoing Colorectal Cancer Surgery: U.S. Nationwide Inpatient Sample Analysis

Simple Risk Score for Colon Cancer Identifies People Likely to Benefit from Colonoscopy.

Risk-stratified screening and colorectal cancer incidence and mortality: A retrospective study from the prostate, lung, colorectal, and ovarian cancer screening trial

AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review

Systematic review: risk prediction models for metachronous advanced colorectal neoplasia after polypectomy

Performance of the Asia–Pacific Colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta‐analysis and systematic review